Medical News / Tapering of Biologics for Rheumatoid Arthritis Successful, Cost-Effective in Patients with Low Disease Activity

Patients with rheumatoid arthritis and low disease activity or remission may be able to successfully taper their treatment with biologic disease-modifying antirheumatic drugs (bDMARDS), according to the results of a recent study presented at the 2018 ACR/ARHP Annual Meeting, October 19-24, 2018, in Chicago, Illinois.

read more

MORE MEDICAL NEWS
New Research at DDW Shows Preferences for Colorectal Cancer Screenings
In data presented as a late-breaking abstract during Digestive Disease Week (DDW) 2023 in Chicago, a ... read more
DDW 2023: Direct Endoscopic Necrosectomy Significantly Improves Treatment Success in Infected Necrotizing Pancreatitis
Direct endoscopic necrosectomy at index session, as opposed to the step-up approach, for patients with infected ... read more
From DDW 2023: Restoring Gut Microdiversity Could Help Alleviate Symptoms of Post-Acute COVID-19 Syndrome
Gut dysbiosis is often linked to persistent multi-system symptoms after SARS-CoV-2 infections or post-acute COVID-19 syndrome. In ... read more
Linda S. Lee, MD, Talks About Using AI During DDW 2023
The explosion of artificial intelligence has permeated through basically all walks of life, including medicine. In an ... read more